Search results
Showing results for
A multi-site project, called ‘What’s the STORY?’ has received funding from UK Research and Innovation (UKRI) to assess novel coronavirus infection rates in children and teenagers across the UK. Given the importance of this study to the national Covid-19 response it has been deemed a priority study for the National Institute for Health Research’s (NIHR) Urgent Public Health Response.
Longitudinal profiles of executive functioning from infancy to 5 years of age-A FinnBrain Birth Cohort Study.
Journal article
Karonen A. et al, (2026), Child Dev
Maternal views on RSV vaccination in the UK's second season.
Journal article
O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.
Conference paper
Gagnon LL. et al, (2026), Leukemia
Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.
Journal article
Weight CM. et al, (2026), J Infect Dis
Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.
Journal article
Turan G. et al, (2026), Vaccines (Basel), 14
Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.
Journal article
Bijukchhe SM. et al, (2026), Lancet Infect Dis
Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.
Journal article
Woffindale C. et al, (2026), Mol Ther Nucleic Acids, 37
Human-specific features of the cerebellum and ZP2-regulated synapse development.
Journal article
Kim S-K. et al, (2026), Cell
Predicting how perturbations reshape cellular trajectories with PerturbGen
Preprint
Chi Hao Ly K. et al, (2026)
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.
Journal article
Hausdorff WP. et al, (2026), Vaccine, 75
13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.
Journal article
Tembo G. et al, (2026), Vaccine, 75
Advances in Alphavirus and Flavivirus Research II.
Journal article
Kim YC. and Reyes-Sandoval A., (2026), Viruses, 18
Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.
Journal article
Fatunla OAT. et al, (2026), BMJ Paediatr Open, 10
Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.
Journal article
Alam N. et al, (2026), EMBO Mol Med
Broad lessons from negative trials in rare diseases.
Journal article
Servais L. and Oskoui M., (2026), Lancet Neurol, 25, 215 - 217
Advancing treatment of spinal muscular atrophy through inhibition of the myostatin signaling pathway.
Journal article
Finkel RS. et al, (2026), Expert Rev Neurother, 26, 211 - 225
The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.
Journal article
Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235
CMV Preventive and Treatment Studies in Children Undergoing Haematopoietic Stem Cell Transplant: A Systematic Review.
Journal article
Fusani L. et al, (2026), Rev Med Virol, 36
Pneumococcal colonisation and mucosal immunity in adults with asthma following experimental human challenge
Journal article
Reiné J. et al, (2026), BMJ Immunology, 1, e000012 - e000012
Securing the future of immunisation: ESCMID’s vision
Journal article
Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167